Erbil Arık

Dr. Erbil Arık

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Sakarya Medical Journal
Verified
Journal Article
Open access
PDF file
EAErbil Arık
Erbil Arık
AEAsım ESENKAYA
Asım ESENKAYA
FAFatih Altintoprak
Fatih Altintoprak
Amaç: Çalışmamızda perkütan kolesistostominin (PK) hastaların klinik ve laboratuvar bulgularına etkisini araştırdık. Gereç ve Yöntem: Çalışmamıza Şubat 2017 ile Kasım 2018 tarihleri arasında PK yapılan 36 hasta dahil edildi.Hastaların işlem öncesi ve sonrası klinik ve laboratuvar bulguları retrospektif olarak tarandı. Bulgular: Hastalarımızda rekürrens görülmemiştir. PK işlemi ile ilişkili mortalite ya da komplikasyon izlenmemiştir. Kateterin takılı kalma süresi 50,2 ± 26,1 gün, hastane yatış süresi 7,5 ± 5,2 gün olarak belirlenmiştir. Total bilirubin değeri ve beyaz küre sayısı yüksek olan hasta sayısında işlem öncesi ve sonrası arasında istatistiksel olarak anlamlı fark saptanmıştır. ALT, ALP, CRP, beyaz küre sayısı, total ve direkt bilirubin parametrelerinin işlem öncesi ve sonrası değerleri arasında da istatistiksel olarak anlamlı fark saptanmıştır. Tokyo kılavuzu evresi ile yoğun bakım ihtiyacı arasında istatistiksel olarak anlamlı fark saptanmış olup yoğun bakımda tedavi gösteren tüm hastalar evre 3’tür.PK sonrasında cerrahiye giden hastaların yaş ortalaması diğer gruba göre daha yüksektir. Sonuç: İşlem sonrasında beyaz küre sayısı ve CRP değerinde anlamlı düşüş ve hastaların çoğunluğunda klinik düzelme görülmesi PK’nin A.K kaynaklı enflamatuar süreçleri olumlu yönde etkilediğini göstermektedir. Çalışmamızda işlem sonrasında ALT ve ALP değerlerinde anlamlı düşüş saptanmış olup, bu bulgu bildiğimiz kadarıyla literatürde ilk kez tanımlanmıştır.

28 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
OTOnur Taydas
Onur Taydas
EAErbil Arık
Erbil Arık
MDMehmet Ali Durmuş
Mehmet Ali Durmuş
VTVOLKAN TASCİ
VOLKAN TASCİ
ÖTÖMER FARUK TOPALOĞLU
ÖMER FARUK TOPALOĞLU
MOMehmet Halil Ozturk
Mehmet Halil Ozturk
This narrative review evaluates the current role of interventional radiology in the diagnosis and treatment of parathyroid disorders. In patients with biochemically confirmed hyperparathyroidism but inconclusive or discordant preoperative localization imaging, image-guided interventions can help establish a diagnosis that can alter management. This review outlines the current diagnostic and therapeutic modalities for the study of parathyroid pathology from the interventional radiologist’s perspective, highlighting novel techniques and their growing clinical adoption. The combination of ultrasound-guided fine-needle aspiration biopsy and measurement of parathyroid hormone (PTH) in the needle washout fluid can improve diagnostic specificity by providing biochemical evidence of parathyroid tissue. This is particularly useful for lesions that are difficult to differentiate from thyroid nodules or cervical lymph nodes based solely on imaging characteristics. Despite this, no widely accepted cut-off washout PTH level has yet been established. Due to the differences in assay techniques and laboratory procedures, results should be interpreted in conjunction with clinical findings and concomitant biochemical parameters. Ultrasound-guided thermal ablation techniques, especially radiofrequency and microwave ablation, have recently been reported as minimally invasive alternatives or adjuvants to surgery in appropriately selected patients. Evidence supporting parathyroid embolization is limited, but it may be considered a potential salvage option for persistent or recurrent disease. Given that most of the current evidence is derived from retrospective case series, multicenter prospective studies for technical standardization and long-term outcomes evaluation are clearly needed.

Verified
Journal Article
Open access
PDF file
VTVOLKAN TASCİ
VOLKAN TASCİ
EAErbil Arık
Erbil Arık
MBMuhammed Said Beşler
Muhammed Said Beşler
ATAli Fuat Tekin
Ali Fuat Tekin
MDMehmet Ali Durmuş
Mehmet Ali Durmuş
MÖMehmet Halil Öztürk
Mehmet Halil Öztürk
Background/Objectives: Drug-coated balloons (DCBs) deliver paclitaxel to the vessel wall and leave nothing behind, which makes them mechanistically appealing here, yet head-to-head data confined to the isolated popliteal/SFA segment are still scarce. We directly compared 12-month hemodynamic, symptomatic, and patency loss outcomes between DCB and plain old balloon angioplasty (POBA) in this anatomical setting. Methods: We retrospectively reviewed 401 consecutive endovascular procedures performed at a single center between January 2021 and December 2024 for isolated popliteal and/or SFA disease, comprising 179 DCB and 222 POBA cases. 12-month endpoints of composite clinical success, asymptomatic recovery, and composite patency loss were analyzed. The composite patency loss endpoint was further fitted to a multivariable logistic regression with baseline ABI, baseline Rutherford category, lesion length, and total occlusion as covariates. The composite patency loss endpoint was further fitted to a multivariable logistic regression with baseline ABI, baseline Rutherford category, lesion length, and total occlusion as covariates, designated as the principal effect estimate. Kaplan–Meier cumulative incidence plots are presented descriptively only. Results: The study population comprised 401 patients (mean age 68.4 ± 10.6 years; 316 male [78.8%]), with 179 in the DCB arm (mean age 65.3 ± 10.5 years; 80.4% male) and 222 in the POBA arm (mean age 71.0 ± 9.8 years; 77.4% male). DCB-treated lesions started out more advanced: longer (94.5 ± 48.2 vs. 82.7 ± 43.3 mm; p = 0.010), more often totally occluded (39.7% vs. 19.4%; p < 0.001), and weighted toward TASC II C/D (p < 0.001). Mean ABI improved by +0.27 in both arms, with no detectable between-arm difference (p = 0.860; within-arm p < 0.001 in each). Asymptomatic recovery at 12 months was more common after DCB (62.0% vs. 51.4%; p = 0.033; OR 1.55, 95% CI 1.04–2.31), and composite patency loss was roughly halved (6.7% vs. 12.6%; p = 0.050; OR 0.50, 95% CI 0.25–1.01). Documented TLR (4.5% vs. 7.2%; p = 0.251) and composite clinical success (86.6% vs. 82.4%; p = 0.255) did not reach significance. Conclusions: Across 401 real-world procedures in isolated popliteal and/or SFA disease, mean ABI gain was identical between arms, yet DCB delivered measurably more complete symptomatic recovery and a near-significant halving of composite patency loss at 12 months, with both signals robust to multivariable adjustment. In this real-world setting, DCB was associated with more complete symptomatic recovery and a numerically lower composite patency loss rate; these findings are hypothesis-generating and require confirmation in adequately powered randomized trials.

11 May 2023 in Radiology Case Reports
Verified
Journal Article
Open access
OOOmer Onder
Omer Onder
IDIsmail Dilek
Ismail Dilek
CECem Erdogan
Cem Erdogan
IOIlke Toker Onder
Ilke Toker Onder
EAErbil Arık
Erbil Arık
CACavide Ali Algan
Cavide Ali Algan
Endometrioma superinfection is a rare clinical entity that may cause diagnostic confusion and can be complicated by rupture, peritonitis, sepsis, and even death. Therefore, early diagnosis is crucial for appropriate patient management. Since clinical findings can be mild or nonspecific, radiological imaging is frequently used for diagnostic purposes. From a radiological perspective, it can be challenging to distinguish the presence of infection in an endometrioma. Complex cyst structure, wall thickening, increased peripheral vascularization, nondependent air bubbles, and surrounding inflammatory changes have been reported as potential US and CT findings suggestive of superinfection. On the other hand, there is a gap in the literature regarding MRI findings. To the best of our knowledge, this is the first case report in the literature to discuss MRI findings and temporal evolution of infected endometriomas.

22 February 2023 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
EAErbil Arık
Erbil Arık
YGYasemin Gunduz
Yasemin Gunduz
GCGozde Cakirsoy Cakar
Gozde Cakirsoy Cakar
HEHalil Elden
Halil Elden
Glomus tumors are rare vascular tumors that originate in the glomus bodies. These tumors are uncommon in the head and neck region and are extremely rare in the nasal cavity. Intranasal glomus tumors mostly have a clinical and radiologic indolent behavior. This report presents the clinical, pathological, and radiological features of a 60-year-old female patient with a glomus tumor that has an atypical size and location.

28 June 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
YGYasemin Gunduz
Yasemin Gunduz
OKOguz Karabay
Oguz Karabay
AEAli Fuat Erdem
Ali Fuat Erdem
EAErbil Arık
Erbil Arık
MÖMehmet Halil Öztürk
Mehmet Halil Öztürk
Background/aim: There is no study in the literature in which only chest computed tomography (CT) findings of deceased cases obtained at admission were examined, and the relationship between these findings and mortality was evaluated. Materials and methods: In this retrospective study, a total of 117 deceased patients with COVID-19 infection confirmed by positive polymerase chain reaction and undergone chest CT were enrolled. We evaluated initial chest CT findings and their relationship, location, prevalence, and the frequency with mortality. Results: The mean age of patients was 73 +/- 18 years; 71 of all patients were male and 46 were female. The predominant feature was pure ground-glass opacity (GGO) lesion (82.0%), and 59.8% of cases had pure consolidation. There was no cavitation or architectural distorsion. Pericardial effusion was found in 9.4% the patients, and pleural effusions were found in 15.3% of them. Mediastinal lymphadenopathy was only 11.9% in total. Conclusion: In deceased patients, on admission CTs, pure consolidation, pleural and pericardial effusion, mediastinal LAP were more common than ordinary cases. It was these findings that should also raise the concern when they were seen on chest CT; therefore, these radiologic features have the potential to represent prognostic imaging markers in patients with COVID-19 pneumonia.